{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:59:53Z","timestamp":1791140393915,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031501","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T22:29:31Z","timestamp":1329431371000},"page":"e31501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":152,"title":["Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid"],"prefix":"10.1371","volume":"7","author":[{"given":"Christian","family":"Czech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Kastler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.287.18.2335","article-title":"Alzheimer disease.","volume":"287","author":"JL Cummings","year":"2002","journal-title":"Jama"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome.","volume":"82","author":"CL Masters","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.","volume":"6","author":"B Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.","volume":"55","author":"WE Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.","volume":"7","author":"CC Rowe","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymeth.2007.06.012","article-title":"Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.","volume":"44","author":"M Otto","year":"2008","journal-title":"Methods"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1570159043359666","article-title":"Disease Modifying Therapeutic Strategies in Alzheimer's Disease Targeting the Amyloid Cascade.","volume":"2","author":"C Czech","year":"2004","journal-title":"Current Neuropharmacology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/14622416.7.7.1055","article-title":"Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.","volume":"7","author":"G Schlotterbeck","year":"2006","journal-title":"Pharmacogenomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0731-7085(93)80171-V","article-title":"600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances.","volume":"11","author":"BC Sweatman","year":"1993","journal-title":"J Pharm Biomed Anal"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2007.05.021","article-title":"The use of metabolomics for the discovery of new biomarkers of effect.","volume":"172","author":"B van Ravenzwaay","year":"2007","journal-title":"Toxicol Lett"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-313x.2000.00774.x","article-title":"Technical advance: simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry.","volume":"23","author":"U Roessner","year":"2000","journal-title":"Plant J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jat\/26.1.17","article-title":"Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine.","volume":"26","author":"H Yamada","year":"2002","journal-title":"J Anal Toxicol"},{"key":"ref14","article-title":"R: A language and environment for statistical computing.","year":"2008"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/biostatistics\/kxm010","article-title":"Penalized logistic regression for detecting gene interactions.","volume":"9","author":"M Park","year":"2008","journal-title":"Biostatistics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.","volume":"39","author":"MH Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatic memory dysfunction.","volume":"217","author":"RTDR Bartus","year":"1982","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(94)90064-7","article-title":"Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia.","volume":"177","author":"H Tohgi","year":"1994","journal-title":"Neurosci Lett FIELD Full Journal Title:Neuroscience Letters"},{"key":"ref19","first-page":"164","article-title":"Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.","volume":"32","author":"W Bondareff","year":"1982","journal-title":"Neurology FIELD Full Journal Title:Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.490270419","article-title":"Neurotransmitter changes in Alzheimer's disease: implications for diagnostics and therapy.","volume":"27","author":"KJ Reinikainen","year":"1990","journal-title":"J Neurosci Res FIELD Full Journal Title:Journal of Neuroscience Research"},{"key":"ref21","first-page":"25","article-title":"Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.","volume":"154","author":"R Elrod","year":"1997","journal-title":"Am J Psychiatry FIELD Full Journal Title:The American journal of psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2004.11.011","article-title":"Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.","volume":"27","author":"GS Watson","year":"2006","journal-title":"Neurobiol Aging FIELD Full Journal Title:Neurobiology of Aging"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(88)80061-7","article-title":"Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.","volume":"9","author":"KJ Reinikainen","year":"1988","journal-title":"Neurobiol Aging FIELD Full Journal Title:Neurobiology of aging"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0278-5846(86)90006-0","article-title":"CSF neurotransmitter markers in Alzheimer's disease.","volume":"10","author":"MF Beal","year":"1986","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry FIELD Full Journal Title:Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02257623","article-title":"Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.","volume":"4","author":"H Tohgi","year":"1992","journal-title":"J Neural Transm: Parkinson's Dis Dementia Sect FIELD Full Journal Title:Journal of Neural Transmission: Parkinson's Disease and Dementia Section"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1176\/ajp.143.3.300","article-title":"Cortisol and Alzheimer's disease, I: Basal studies.","volume":"143","author":"KL Davis","year":"1986","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00406-008-0838-3","article-title":"Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau\/Abeta 1\u201342 ratios in CSF in patients with mild Alzheimer's disease dementia.","volume":"259","author":"C Laske","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neurobiolaging.2007.07.007","article-title":"CSF cortisol in Alzheimer's disease and mild cognitive impairment.","volume":"30","author":"J Popp","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2000-23-401","article-title":"Response of the hypothalamic-pituitary-adrenal axis to lumbar puncture induced stress.","volume":"2","author":"AJ Lerner","year":"2000","journal-title":"J Alzheimers Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1753-4887.2010.00344.x","article-title":"Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.","volume":"68","author":"RJ Wurtman","year":"2010","journal-title":"Nutr Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1258\/ebm.2011.010355","article-title":"Vascular and metabolic dysfunction in Alzheimer's disease: a review.","volume":"236","author":"IV Murray","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-3223(02)01451-8","article-title":"Alzheimer's disease and total plasma aminothiols.","volume":"53","author":"A McCaddon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1742-1241.2009.02026.x","article-title":"Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature.","volume":"63","author":"T Vogel","year":"2009","journal-title":"Int J Clin Pract"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-2009-1187","article-title":"Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.","volume":"18","author":"J Popp","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.","volume":"5","author":"AD Smith","year":"2010","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/epr.10.75","article-title":"Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.","volume":"7","author":"YS Choi","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T15:04:10Z","timestamp":1593702250000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031501"}},"subtitle":[],"editor":[{"given":"Gemma","family":"Casadesus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}